Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yunju Ma
Observed names:
Ma, Yunju,
Yun-Ju Ma
Institution:
First Affiliated Hospital of Soochow University
Observed institutions:
Soochow University,
First Affiliated Hospital of Soochow University,
National Cheng Kung University Hospital,
National Cheng Kung University
ORCID:
0000-0003-1741-6849
Observed ORCID:
0000-0003-1741-6849
OpenAlex ID:
A5007315226
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.
2022
·
Yun-Ju Ma
, Hai-Ping Dai
, et al.
·
PubMed
·
50
Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
2019
·
Yunju Ma
, Changju Qu
, et al.
·
Bone Marrow Transplantation
·
35
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation
2021
·
Xiaowen Tang
, Benigno C. Valdez
, et al.
·
Bone Marrow Transplantation
·
27
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
2023
·
Yunju Ma
, Haiping Dai
, et al.
·
Experimental Hematology and Oncology
·
25
PDF
Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations
2021
·
Changju Qu
, Yaohua Song
, et al.
·
Bone Marrow Transplantation
·
15
USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression
2025
·
Shuoyi Jiang
, Liyang Jiang
, et al.
·
Oncogene
·
13
Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients
2024
·
Tingting Li
, Qingya Cui
, et al.
·
Leukemia Research
·
3
Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors
2022
·
Lingling Liu
, Qingya Cui
, et al.
·
Frontiers in Immunology
·
3
PDF
Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia
2024
·
Ruixue Ma
, Yunju Ma
, et al.
·
Clinical and Applied Thrombosis/Hemostasis
·
2
Decitabine in Combination with Fludarabine and Cyclophosphamide As Lymphodepletion Regimen Followed By CD19/CD22 Bispecific Targeted CAR-T Therapy Significantly Improves Survival in Relapsed/Refractory B-ALL Patients: A Pilot Study
2021
·
Yunju Ma
, Changju Qu
, et al.
·
Blood
·
2
Sequential Infusion of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cells: A Promising Treatment Strategy for Refractory Immune-Mediated Platelet Transfusion Refractoriness
2024
·
Yunju Ma
, Qingya Cui
, et al.
·
Blood
·
1
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature
2024
·
Mingqi Yang
, Lian Bai
, et al.
·
OncoTargets and Therapy
·
1
PDF
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation
2024
·
Xuanqi Cao
, Zheng Li
, et al.
·
Annals of Hematology
·
1
Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia
2019
·
Yunju Ma
, Changju Qu
, et al.
·
Blood
·
1
Sequential Infusion of Anti-CD19 and Anti-BCMA CAR-T Cells Improves Transplant Outcomes in Patients with Refractory Immune-Mediated Platelet Transfusion Refractoriness
2025
·
Yunju Ma
, Qingya Cui
, et al.
·
Transplantation and Cellular Therapy
Sequential Infusion of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cells: A Promising Strategy for Treating Refractory Immune-Mediated Platelet Transfusion Refractoriness
2025
·
Yunju Ma
, Qingya Cui
, et al.
·
SSRN Electronic Journal
Chidamide Combined with a Modified Bu-Cy Conditioning Regimen Improves Survival in Patients with T-Cell Acute Lymphoblastic Leukemia/Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2023
·
Xuanqi Cao
, Zheng Li
, et al.
·
Blood
Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2019
·
Xiaowen Tang
, Benigno C. Valdez
, et al.
·
Blood
Vancomycin-resistant Enterococcus gallinarum outbreak in a pediatric intensive care unit
2015
·
Yun-Ju Ma
, Li-Rong Wang
, et al.
·
Journal of Microbiology Immunology and Infection
PDF
Show more works
View as search
Works count:
22
Citation count:
179
H-index:
6
I10-index:
6
Year
Topic
Type